Group 1: Goodman Group (GMG) - Goodman Group's share price has decreased approximately 5.9% since the beginning of 2025, making it the largest ASX-listed property group in 2025 with operations across multiple continents including Australia, New Zealand, the UK, Japan, the US, and Brazil [1] - The company specializes in warehouses, large-scale logistics facilities, and business and office parks, aiming to build long-term relationships with customers and deliver high-quality assets [2] - The current dividend yield for Goodman Group shares is around 0.88%, which is lower than its 5-year average of 1.28%, indicating a potential decline in dividends or an increase in share price [6] Group 2: Sonic Healthcare (SHL) - Sonic Healthcare, listed in April 1987, is one of the largest pathology businesses globally, with operations in Australia, New Zealand, Europe, and North America, offering services such as laboratory medicine, pathology, diagnostic imaging, and corporate medical services [3][4] - The current price-sales ratio for Sonic Healthcare shares is 1.19x, which is below its 5-year long-term average of 1.94x, suggesting that SHL shares may be undervalued [7] - Sonic Healthcare focuses on acting in the best interests of doctors and patients, striving for medical excellence and being a desirable workplace [4]

Core Insights - Reece Ltd has seen a significant decline in its share price, down approximately 48.1% since the start of 2025, while HUB24's share price is up 113.9% from its 52-week low [1] - Reece Ltd has diversified its offerings beyond plumbing, including services in irrigation, pools, civil construction, and HVAC systems [2] - HUB24 has established itself in the wealth management sector, providing software and platform solutions for financial advice and investment management [3] Reece Ltd - Reece Ltd is Australia's largest plumbing and bathroom supplies business, with over 100 years of operation [1] - The company has experienced steady revenue growth, although its dividend yield has typically been low, it has maintained consistent payments [2] - Currently, Reece Ltd shares have a dividend yield of around 2.18%, which is higher than its 5-year average of 1.06%, indicating potential growth in dividends [7] HUB24 - HUB24, founded in 2007, has quickly become a key player in the wealth management industry [3] - The company's core products include the HUB24 platform, Class, and myprosperity, which enhance service delivery for financial advisers and their clients [4] - HUB24 was recognized as the Overall Best Platform in the Adviser Ratings Financial Advice Landscape Report for 2024, highlighting its competitive edge in service quality [5] Valuation Metrics - For Reece Ltd, analyzing dividend yield over time can provide insights into the company's stability and profit distribution [6] - HUB24's current price-sales ratio is 26.07x, significantly above its 5-year average of 13.32x, suggesting that its shares may be overvalued [8]

Company Overview - ResMed is a medical equipment company based in San Diego, California, originally founded in Australia, specializing in cloud-connectable CPAP machines for obstructive sleep apnea treatment [2] - The company operates globally with over 10,000 employees and a presence in more than 140 countries, divided into two primary business units: Sleep and Respiratory Care, and Software as a Service (SaaS) [3] - Netwealth is a wealth management software business that provides a platform for financial planners, with over 140,000 account holders and $88 billion in funds under administration as of 2024 [5] Business Model and Services - ResMed's Sleep and Respiratory Care unit offers industry-leading CPAP machines, catering to a wide range of patients from those needing nightly therapy to those requiring life-support ventilation [3] - The SaaS unit provides software for durable or home medical equipment, enhancing out-of-hospital care [3][4] - Netwealth's platform allows users to manage investments, track performance, and access financial reports through a user-friendly interface [6] Financial Performance and Valuation - ResMed shares have a current price-sales ratio of 5.63x, significantly lower than its 5-year average of 8.70x, indicating potential undervaluation or increased sales [8] - In contrast, Netwealth shares trade at a price-sales ratio of 30.23x, above its 5-year average of 23.72x, suggesting a higher valuation relative to historical performance [9]